Cytek Biosciences Inc.
CTKB | NASDAQ
$5.55
+$0.27 (+5.11%)
Sep 22, 2026, 11:22 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 206.71M | 204.17M | 201.49M | 196.83M | 196.04M | 197.05M | 200.45M | 201.21M | 197.71M | 200.79M | 193.01M | 183.12M | 175.59M | 166.06M | 164.04M | 154.59M | 148.49M | 138.74M | 127.95M | 119.68M | 110.4M | 99.12M |
Cost of Revenue | 96.68M | 98.61M | 97.03M | 91.6M | 89.35M | 88.8M | 89.35M | 90.71M | 89.04M | 89.39M | 83.59M | 77.37M | 70.16M | 64.23M | 63.06M | 59.36M | 58.84M | 53.91M | 48.81M | 44.72M | 41.1M | 41.3M |
Gross Profit | 110.03M | 105.56M | 104.46M | 105.23M | 106.68M | 108.25M | 111.11M | 110.5M | 108.68M | 111.4M | 109.43M | 105.75M | 105.44M | 101.84M | 100.97M | 95.24M | 89.65M | 84.84M | 79.14M | 74.96M | 69.3M | 57.82M |
Operating Income | -44.65M | -43.87M | -40.39M | -31.81M | -26.86M | -24.76M | -20.52M | -23.65M | -25.82M | -26.42M | -27.85M | -27.63M | -19.85M | -11.61M | -1.8M | -571K | 966K | 5.67M | 9.16M | 15.72M | 19.53M | 15.5M |
Interest Income | 2.76M | 2.5M | 2.22M | 7.79M | 8.65M | 9.51M | 10.36M | 5.66M | 5.85M | 5.63M | 6.41M | 7.59M | 7.55M | 6.74M | 4.62M | 2.01M | 439K | 57K | 49K | 36K | 27K | 34K |
Pretax Income | -40.82M | -35.95M | -29.84M | -15.49M | -7.56M | -7.97M | -5.7M | -11.91M | -16.25M | -15.66M | -15.71M | -15.71M | -9.67M | -4.48M | 1.26M | -2.41M | -2.19M | 2.48M | 5.94M | 13.5M | 18.32M | 15.24M |
Net Income | -80.58M | -74M | -66.54M | -12.82M | -6.4M | -11.25M | -6.02M | -10.16M | -17.56M | -11.51M | -12.15M | -14.12M | -6M | -2.21M | 2.58M | -2.14M | -2.39M | 878K | 3M | 9.79M | 14.91M | 20.35M |
Selling & General & Admin | 117.42M | 113.08M | 108.38M | 99.8M | 95.39M | 93.68M | 92.23M | 93.6M | 92.66M | 93.85M | 93.12M | 90.35M | 84.77M | 76.64M | 67.92M | 63.62M | 59.07M | 51.79M | 45.55M | 37.49M | 30.72M | 26.55M |
Research & Development | 37.26M | 36.35M | 36.47M | 37.23M | 38.16M | 39.33M | 39.4M | 40.55M | 41.84M | 43.97M | 44.15M | 43.03M | 40.51M | 36.81M | 34.86M | 32.19M | 29.62M | 27.37M | 24.44M | 21.75M | 19.05M | 15.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 154.68M | 149.43M | 144.85M | 137.03M | 133.54M | 133.01M | 131.63M | 134.15M | 134.49M | 137.82M | 137.27M | 133.38M | 125.28M | 113.44M | 102.78M | 95.81M | 88.69M | 79.17M | 69.99M | 59.24M | 49.77M | 42.32M |
Interest Expense | 1.76M | 1.9M | 1.92M | 1.2M | 824K | 544K | 694K | 1.09M | 1.56M | 1.84M | 2.07M | 2.36M | 2.42M | 2.66M | 2.57M | 2.38M | 2.17M | 1.96M | 1.74M | 1.58M | 1.14M | 708K |
Selling & Marketing Expenses | 49.62M | 48.58M | 49.44M | 48.18M | 48.95M | 49.08M | 49.11M | 48.8M | 48.45M | 50.55M | 49.15M | 46.62M | 43.35M | 37.42M | 33.23M | 32.51M | 30.25M | 27.39M | 24.71M | 20.97M | 18.25M | 15.73M |
Cost & Expenses | 251.36M | 248.04M | 241.88M | 228.63M | 222.9M | 221.81M | 220.98M | 224.86M | 223.53M | 227.2M | 220.86M | 210.74M | 195.44M | 177.67M | 165.84M | 155.17M | 147.53M | 133.07M | 118.79M | 103.96M | 90.87M | 83.62M |
Income Tax Expense | 39.76M | 38.06M | 36.7M | -2.67M | -1.16M | 3.28M | 320K | -1.75M | 1.3M | -4.15M | -3.56M | -1.77M | -3.82M | -2.31M | -1.22M | -11K | 420K | 1.72M | 2.91M | 3.71M | 3.41M | -5.11M |
Shares Outstanding (Basic) | 129.46M | 128.7M | 128.17M | 127.55M | 126.93M | 128.34M | 129.21M | 131M | 131.44M | 130.92M | 130.71M | 136.17M | 135.92M | 135.49M | 135M | 134.71M | 134.4M | 133.9M | 108.32M | 108.32M | 130.81M | 124.82M |
Shares Outstanding (Diluted) | 129.46M | 128.7M | 128.17M | 127.55M | 126.93M | 128.34M | 129.21M | 132.79M | 131.44M | 130.92M | 130.71M | 136.17M | 135.92M | 135.49M | 137.03M | 138.71M | 134.4M | 133.9M | 113.64M | 113.64M | 130.81M | 126.92M |
EPS (Basic) | -0.62 | -0.58 | -0.52 | -0.10 | -0.05 | -0.09 | -0.05 | -0.08 | -0.13 | -0.08 | -0.09 | -0.10 | -0.04 | -0.02 | 0.02 | -0.01 | 0 | 0.02 | 0.04 | 0.08 | 0.12 | 0.16 |
EPS (Diluted) | -0.62 | -0.58 | -0.52 | -0.10 | -0.05 | -0.09 | -0.05 | -0.08 | -0.13 | -0.08 | -0.09 | -0.10 | -0.04 | -0.02 | 0.02 | -0.01 | 0 | 0.02 | 0.04 | 0.08 | 0.12 | 0.16 |
EBITDA | -30.14M | -22.15M | -15.94M | -18.13M | -10.83M | -12.03M | -10.03M | -649K | -4.77M | -4.76M | -6.03M | -6.3M | -2M | 2.68M | 8.8M | 3.76M | 3.2M | 6.98M | 8.92M | 15.79M | 20.16M | 16.62M |
EBIT | -39.05M | -34.05M | -27.92M | -29.81M | -22.25M | -22.95M | -20.52M | -10.82M | -14.69M | -13.82M | -13.64M | -13.34M | -7.25M | -1.82M | 3.83M | -32K | -15K | 4.44M | 7.68M | 15.08M | 19.46M | 15.95M |
Depreciation & Amortization | 8.92M | 11.9M | 11.98M | 11.67M | 11.42M | 10.91M | 10.49M | 10.17M | 9.92M | 9.06M | 7.61M | 7.04M | 5.26M | 4.5M | 4.97M | 3.79M | 3.21M | 2.55M | 1.24M | 715K | 705K | 665K |
Add to Watchlist
Select watchlists to add or remove CTKB